Amedeo Smart

Free Medical Literature Service



Gastric Cancer

  Free Subscription

Articles published in
J Cancer Res Clin Oncol
    September 2021
  1. PAN Z, Fu Z, Luo C, Bao Y, et al
    CDH1 germline mutations in a Chinese cohort with hereditary diffuse gastric cancer.
    J Cancer Res Clin Oncol. 2021 Sep 18. pii: 10.1007/s00432-021-03775.
    >> Share

    May 2021
  2. XIE J, Pang Y, Li X, Wu X, et al
    The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.
    J Cancer Res Clin Oncol. 2021 May 18. pii: 10.1007/s00432-021-03654.
    >> Share

  3. LIU Z, Shi M, Li X, Song S, et al
    HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma.
    J Cancer Res Clin Oncol. 2021;147:1315-1324.
    >> Share

    April 2021
  4. ZHANG Y, Wang F, Sun HR, Huang YK, et al
    Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer.
    J Cancer Res Clin Oncol. 2021 Apr 23. pii: 10.1007/s00432-021-03633.
    >> Share

  5. WAN Q, Zhao R, Xia L, Wu Y, et al
    Inflammatory bowel disease and risk of gastric, small bowel and colorectal cancer: a meta-analysis of 26 observational studies.
    J Cancer Res Clin Oncol. 2021;147:1077-1087.
    >> Share

    March 2021
  6. ZHANG Q, Ni Y, Zhi X, Wang J, et al
    Involvement of APRIL in Helicobacter pylori-related gastric cancer.
    J Cancer Res Clin Oncol. 2021 Mar 18. pii: 10.1007/s00432-021-03574.
    >> Share

  7. NA JE, Lee H, Min YW, Min BH, et al
    Clinical feasibility and oncologic safety of primary endoscopic submucosal dissection for clinical submucosal invasive early gastric cancer.
    J Cancer Res Clin Oncol. 2021 Mar 5. pii: 10.1007/s00432-021-03581.
    >> Share

    February 2021
  8. JIANG L, Gong X, Liao W, Lv N, et al
    Molecular targeted treatment and drug delivery system for gastric cancer.
    J Cancer Res Clin Oncol. 2021 Feb 7. pii: 10.1007/s00432-021-03520.
    >> Share

  9. OHNUMA H, Sato Y, Onoyama N, Hamaguchi K, et al
    Survival benefit of conversion surgery after intensive chemotherapy for unresectable metastatic gastric cancer: a propensity score-matching analysis.
    J Cancer Res Clin Oncol. 2021 Feb 3. pii: 10.1007/s00432-021-03516.
    >> Share

    January 2021
  10. FAN Y, Liu M, Li S, Yu J, et al
    Surgical and oncological efficacy of laparoscopic-assisted total gastrectomy versus open total gastrectomy for gastric cancer by propensity score matching: a retrospective comparative study.
    J Cancer Res Clin Oncol. 2021 Jan 7. pii: 10.1007/s00432-020-03503.
    >> Share

  11. SUN Y, He J, Shi DB, Zhang H, et al
    Elevated ZBTB7A expression in the tumor invasive front correlates with more tumor budding formation in gastric adenocarcinoma.
    J Cancer Res Clin Oncol. 2021;147:105-115.
    >> Share

    August 2020
  12. JIN P, Ji X, Ma S, Kang W, et al
    Indications for adjuvant chemotherapy in patients with pT1N1M0 gastric cancer: a single-center experience.
    J Cancer Res Clin Oncol. 2020 Aug 9. pii: 10.1007/s00432-020-03355.
    >> Share

  13. MA F, Wang B, Xue L, Kang W, et al
    Neoadjuvant chemotherapy improves the survival of patients with neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the stomach.
    J Cancer Res Clin Oncol. 2020;146:2135-2142.
    >> Share

    July 2020
  14. RAMOS MFKP, Pereira MA, de Castria TB, Ribeiro RRE, et al
    Remnant gastric cancer: a neglected group with high potential for immunotherapy.
    J Cancer Res Clin Oncol. 2020 Jul 15. pii: 10.1007/s00432-020-03322.
    >> Share

  15. JIN P, Ji X, Kang W, Li Y, et al
    Artificial intelligence in gastric cancer: a systematic review.
    J Cancer Res Clin Oncol. 2020 Jul 1. pii: 10.1007/s00432-020-03304.
    >> Share

    May 2020
  16. CHENG L, Chen S, Wu W, Kuo ZC, et al
    Gastric cancer in young patients: a separate entity with aggressive features and poor prognosis.
    J Cancer Res Clin Oncol. 2020 May 25. pii: 10.1007/s00432-020-03268.
    >> Share

    March 2020
  17. XIE W, Zhou H, Han Q, Sun T, et al
    Relationship between DLEC1 and PBX3 promoter methylation and the risk and prognosis of gastric cancer in peripheral blood leukocytes.
    J Cancer Res Clin Oncol. 2020 Mar 6. pii: 10.1007/s00432-020-03171.
    >> Share

    February 2020
  18. LIU X, Lin K, Huang X, Xie W, et al
    Overexpression of the human cytomegalovirus UL111A is correlated with favorable survival of patients with gastric cancer and changes T-cell infiltration and suppresses carcinogenesis.
    J Cancer Res Clin Oncol. 2020 Feb 5. pii: 10.1007/s00432-019-03092.
    >> Share

  19. DONG Y, Qiu Y, Deng J, Wang W, et al
    Insufficient examined lymph node count underestimates staging in pN3a patients after curative gastrectomy: a multicenter study with external validation.
    J Cancer Res Clin Oncol. 2020;146:515-528.
    >> Share

    January 2020
  20. ZHANG C, Lin X, Zhao Q, Wang Y, et al
    YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling.
    J Cancer Res Clin Oncol. 2020 Jan 8. pii: 10.1007/s00432-019-03115.
    >> Share

    November 2019
  21. MAEZAWA Y, Sakamaki K, Oue N, Kimura Y, et al
    High gamma-glutamyl hydrolase and low folylpolyglutamate synthetase expression as prognostic biomarkers in patients with locally advanced gastric cancer who were administrated postoperative adjuvant chemotherapy with S-1.
    J Cancer Res Clin Oncol. 2019 Nov 21. pii: 10.1007/s00432-019-03087.
    >> Share

  22. CLAUSEN F, Behrens HM, Kruger S, Rocken C, et al
    Sexual dimorphism in gastric cancer: tumor-associated neutrophils predict patient outcome only for women.
    J Cancer Res Clin Oncol. 2019 Nov 19. pii: 10.1007/s00432-019-03082.
    >> Share

    October 2019
  23. LI Q, Lv M, Jiang H, Wang Y, et al
    A prospective observational study on the optimal maintenance strategy in HER2-positive advanced gastric cancer treated with trastuzumab-based therapy.
    J Cancer Res Clin Oncol. 2019 Oct 30. pii: 10.1007/s00432-019-03060.
    >> Share

  24. LI J, Xu H, Zhang L, Song L, et al
    Malignant ascites-derived organoid (MADO) cultures for gastric cancer in vitro modelling and drug screening.
    J Cancer Res Clin Oncol. 2019 Oct 9. pii: 10.1007/s00432-019-03004.
    >> Share

  25. KAJTAZI Y, Kaemmerer D, Sanger J, Schulz S, et al
    Somatostatin and chemokine CXCR4 receptor expression in pancreatic adenocarcinoma relative to pancreatic neuroendocrine tumours.
    J Cancer Res Clin Oncol. 2019;145:2481-2493.
    >> Share

    September 2019
  26. BOSCH F, Todorova R, Link H, Westphalen CB, et al
    Molecular subtyping of gastric cancer with respect to the growth pattern of lymph-node metastases.
    J Cancer Res Clin Oncol. 2019 Sep 20. pii: 10.1007/s00432-019-03029.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016